115 related articles for article (PubMed ID: 7728975)
1. Tyrosine phosphorylation in mouse mammary hyperplasias.
Said TK; Medina D
Carcinogenesis; 1995 Apr; 16(4):923-30. PubMed ID: 7728975
[TBL] [Abstract][Full Text] [Related]
2. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
Said TK; Luo L; Medina D
Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
[TBL] [Abstract][Full Text] [Related]
5. Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development.
Said TK; Medina D
Carcinogenesis; 1995 Apr; 16(4):823-30. PubMed ID: 7728962
[TBL] [Abstract][Full Text] [Related]
6. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2.
Poon RY; Yamashita K; Adamczewski JP; Hunt T; Shuttleworth J
EMBO J; 1993 Aug; 12(8):3123-32. PubMed ID: 8393783
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells.
Fautsch MP; Eblen ST; Anders RA; Burnette RJ; Leof EB
J Cell Biochem; 1995 Aug; 58(4):517-26. PubMed ID: 7593274
[TBL] [Abstract][Full Text] [Related]
8. Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.
Rak JW; McEachern D; Miller FR
Br J Cancer; 1992 May; 65(5):641-8. PubMed ID: 1586590
[TBL] [Abstract][Full Text] [Related]
9. Morphological and functional properties of TM preneoplastic mammary outgrowths.
Medina D; Kittrell FS; Liu YJ; Schwartz M
Cancer Res; 1993 Feb; 53(3):663-7. PubMed ID: 7678778
[TBL] [Abstract][Full Text] [Related]
10. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
Gollapudi L; Neet KE
J Neurosci Res; 1997 Aug; 49(4):461-74. PubMed ID: 9285522
[TBL] [Abstract][Full Text] [Related]
11. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E.
Bortner DM; Rosenberg MP
Mol Cell Biol; 1997 Jan; 17(1):453-9. PubMed ID: 8972226
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of ribonucleotide reductase R2 protein: in vivo and in vitro evidence of a role for p34cdc2 and CDK2 protein kinases.
Chan AK; Litchfield DW; Wright JA
Biochemistry; 1993 Nov; 32(47):12835-40. PubMed ID: 8251505
[TBL] [Abstract][Full Text] [Related]
13. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
[TBL] [Abstract][Full Text] [Related]
14. Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
Said TK; Bonnette S; Medina D
Cell Prolif; 1996 Nov; 29(11):623-39. PubMed ID: 9105418
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
17. Interactions of apoptosis, proliferation and host age in the regression of the mouse mammary preneoplasia, TM3, carrying an unusual mutation in p53.
Bonnette SG; Kittrell FS; Stephens LC; Meyn RE; Medina D
Carcinogenesis; 1999 Sep; 20(9):1715-20. PubMed ID: 10469615
[TBL] [Abstract][Full Text] [Related]
18. A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.
Holmes JK; Solomon MJ
J Biol Chem; 1996 Oct; 271(41):25240-6. PubMed ID: 8810285
[TBL] [Abstract][Full Text] [Related]
19. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
Medina D; Kittrell FS; Oborn CJ; Schwartz M
Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
[TBL] [Abstract][Full Text] [Related]
20. Role of tyrosine kinase, ODC, and p34cdc2 kinase and cyclin B-associated cdc2 in jejunal enterocyte proliferation, maturation, and exfoliation in diabetic and DFMO-treated rats.
Parekh VV; Hoffman JL; Younoszai MK
J Investig Med; 1999 Sep; 47(8):397-404. PubMed ID: 10510592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
